Cardax Pharma, Inc.
Records under this name other than patents Cardax Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,247,752 | Methods for the synthesis of astaxanthin Term ended Term ended Oct 3, 2025 · From the USPTO record | Term ended | Term ended Oct 3, 2025 | From the USPTO record |
| US 7,521,584 | Carotenoid analogs or derivatives for the inhibition and amelioration of disease Term ended Term ended May 27, 2024 · From the USPTO record | Term ended | Term ended May 27, 2024 | From the USPTO record |
| US 7,320,997 | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease Term ended Term ended Jan 4, 2024 · From the USPTO record | Term ended | Term ended Jan 4, 2024 | From the USPTO record |
| US 8,063,101 | Carotenoid analogs and derivatives for the prevention of platelet aggregation Lapsed on the fee record Ended Nov 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 22, 2023 | From the USPTO record |
| US 9,180,111 | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof Lapsed on the fee record Ended Nov 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 10, 2023 | From the USPTO record |
| US 7,145,025 | Structural carotenoid analogs for the inhibition and amelioration of disease Term ended Term ended Oct 9, 2023 · From the USPTO record | Term ended | Term ended Oct 9, 2023 | From the USPTO record |
| US 7,317,008 | Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury Term ended Term ended Sep 23, 2023 · From the USPTO record | Term ended | Term ended Sep 23, 2023 | From the USPTO record |
| US 7,345,091 | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease Term ended Term ended Jul 29, 2023 · From the USPTO record | Term ended | Term ended Jul 29, 2023 | From the USPTO record |
| US 7,375,133 | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease Term ended Term ended Jul 29, 2023 · From the USPTO record | Term ended | Term ended Jul 29, 2023 | From the USPTO record |
| US 7,592,449 | Structural carotenoid analogs for the inhibition and amelioration of disease Term ended Ended no later than Jul 29, 2023 · From the USPTO record | Term ended | Ended no later than Jul 29, 2023 | From the USPTO record |